Utility of PSA in extracellular vesicles as a follow-up biomarker in prostate cancerAmaia Sandúaon December 30, 2025 at 11:00 am
Adv Lab Med. 2025 Jul 17;6(4):442-449. doi: 10.1515/almed-2025-0023. eCollection 2025 Dec. ABSTRACT OBJECTIVES: Prostate-specific antigen (PSA) circulates bound to extracelular vesicles (EVs). Levels of this PSA form (ev-PSA) are higher in prostate cancer (PCa) compared to benign pathologies and healthy controls, being the PSA extracellular vesicles/serum (ev/srm) ratio potentially useful as PCa diagnostic biomarker. We … Read more